Acne vulgaris - Psychosomatic aspects;Acne vulgaris - Psychosomatische aspekte

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 12, 2006, Pages 1027-1036

  Niemeier, Volker ^a   Kupfer, Jörg ^a   Gieler, Uwe ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acne; Anxiety; Coping behavior; Depression; Psyche; Psychosocial aspects; Psychotherapy

Indexed keywords

ISOTRETINOIN; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR;

ACNE VULGARIS; ANXIETY DISORDER; BEHAVIOR THERAPY; BODY DYSMORPHIC DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; EMOTIONAL DISORDER; HUMAN; PATIENT COUNSELING; PSYCHOANALYSIS; PSYCHOSOMATICS; PSYCHOTHERAPY; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SOCIAL ASPECT; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TREATMENT INDICATION; TREATMENT PLANNING;

ACNE VULGARIS; ADOLESCENT; ADULT; CHILD; COHORT STUDIES; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; DIET; EMOTIONS; FEMALE; HUMANS; MALE; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 33845675604     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.06110.x     Document Type: Review

References (124)

1. Brown SK, Shalita AR. Acne vulgaris. Lancet 1998; 351: 1871-1876.
2. Cunliffe WJ. The sebaceous gland and acne - 40 years on. Dermatology 1998; 196: 9-15.
3. Cunliffe WJ, Holland DB, Clark SM, Stables GI. Comedogenesis: some aetiological, clinical and therapeutic strategies. Dermatology 2003; 206 (1): 11-16.
4. Borelli C, Plewig G, Degitz K. [Pathophysiology of acne.] Hautarzt 2005; 56 (11): 1013-1017.
5. Rzany B, Kahl C. [Epidemiology of acne vulgaris] J Dtsch Dermatol Ges. 2006; 4 (1): 8-9.
6. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 2002; 99 (10): 7148-1753.
7. Gieler U. Psychosomatische Aspekte der Akne. Hautarzt 1988; 39 (Suppl VIII): 117-118.
8. Plewig G, Kligman AM. Akne, Pathogenese, Morphologie, Therapie. Springer-Verlag, Berlin 1978.
9. Layton AM. Psychosocial aspects of acne vulgaris: J Cutan Med Surg 1998; 2 (Suppl 3): 19-23.
10. Korczak D. Psychische Situation der Akne-Patienten. Persö nlichkeitsstruktur und Arzt-Patient-Beziehung. Fortschr Med 1989; 107: 309-313.
11. Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15: 541-545.
12. Dreno B, Poli F. Epidemiology of acne. Dermatology 2003; 206 (1): 7-10.
13. Schäfer T, Nienhaus D, Vieluf D, Berger J, Ring J. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145: 100-104.
14. Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997; 136: 66-70.
15. Gloor M, Eicher C, Wiebelt H, Moser G. Soziologische Untersuchungen bei Acne vulgaris. Über den Krankheitswert der Acne vulgaris. Z Hautkr 1978; 53: 871-880.
16. Niemeier V, Kupfer J, Demmelbauer-Ebner M, Stangier U, Effendy I, Gieler U. Coping with acne vulgaris. Evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology 1998; 196 (1): 108-115.
17. Belisario JC. Acne vulgaris: Its etiology and treatment. Aust J Dermatol 1951; 1: 85-111.
18. Fulton Jr JE, Plewig G, Kligman AM. Effect of chocolate on acne vulgaris. J Am Med Assoc 1969; 210: 2071-2074.
19. Chan JJ, Rohr JB. Acne vulgaris: Yesterday, today and tomorrow. Austral J Dermatol 2000; 41 (Suppl.): 69-72.
20. Bendiner E. Disastrous trade-off: Eskimo health for white "civilization". Hosp Pract 1974; 9: 159-189.
21. Effendy I. Prinzipien der medikamentösen Aknebehandlung. In: Friederich HC (ed): Praxis der Akne-Therapie. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 1992: 19-26.
22. Gupta MA, Gupta AK. The psychological comorbidity in acne. Clin Dermatol 2001; 19: 360-363.
23. Cordain L. Implications for the role of diet in acne. Semin Cutan Med Surg. 2005; 24 (2): 84-91.
24. Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD. High school dietary dairy intake and teenage acne. J Am Acad Dermatol. 2005; 52 (2): 207-14.
25. Magin P, Pond D, Smith W, Watson A. A systematic review of the evidence for "myths and misconceptions" in acne management: diet, face-washing and sunlight. Fam Pract 2005; 22 (1): 62-70.
26. Sulzberger NB, Zaidens SH. Psychogenic factors in dermatologic disorders. Med Clin North Am 1948; 32: 669-688.
27. Shalita AR. Treatment of refractory acne. Dermatology 1980; 3: 23-24.
28. Dahan S, Launais B, Lasserre J. Stress et peau: avis du médecin, avis du patient. Nouv Dermatol 1998; 17: 90-93.
29. Green J, Sinclair RD. Perceptions of acne vulgaris in final year medical student written eamination answers. Australas J Dermatol 2001; 42: 98-101.
30. Lorenz TH, Graham DT, Wolf S. The relation of life-stress and emotions to human sebum secretion and to the mechanism of acne vulgaris. J Lab Clin Med 1953; 41: 11-28.
31. Rosenfield RL, Deplewski D, Kentsis A, Ciletti N. Mechanisms of androgen induction of sebocyte differentiation. Dermatology 1998; 196: 43-46.
32. Lawlis GF, Achterberg J. Acne: the disease and stress. Top Clin Nurs 1983; 5 (2): 23-31.
33. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, Rosenfield R. What is the pathogenesis of acne? Exp Dermatol 2005; 14 (2): 143-52.
34. Zouboulis CC, Bohm M. Neuroendocrine regulation of sebocytes - a pathogenetic link between stress and acne. Exp Dermatol 2004; 13 (Suppl) 4: 31-35.
35. Toyoda M, Morohashi M. New aspects in acne inflammation. Dermatology 2003; 206: 17-23.
36. Glaser R, Kiecolt-Glaser JK, Marucha PT, MacCallum RC, Laskowski BF, Malarkey WB. Stress-related changes in proinflammatory cytokine production in wounds. Arch Gen Psychiatry 1999; 56: 450-456.
37. Kraus S. Stress, acne and skin surface free fatty acids. Psychosom Med 1971; 32: 503-508.
38. Scholz O. Stress und Akne. Dtsch Med Wschr 1987; 112: 516-520.
39. Al'Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130: 199-203.
40. Picardi A, Abeni D. Stressful life events and skin diseases: Disentangling evidence from myth. Psychother Psychosom 2001; 70: 118-136.
41. Harrington CL. Post-adolescent acne and marital break-up. Br J Dermatol 1997; 137: 478-479.
42. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24 (4): 385-96.
43. Chiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 2003; 139 (7): 897-900.
44. Arnold LM, Auchenbach MB, Mc Elroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001; 15 (5): 351-359.
45. Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E. A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry 1997; 58: 341-347.
46. Kent A, Drummond LM. Acne excoriée - a case report of treatment using habit reversal. Clin Exp Dermatol 1989; 14: 163-164.
47. Cotterill JA. Body dysmorphic disorder. Dermatol Clin 1996;14:457-463.
48. Zaidens SH. Dermatological hypochondriasis: a form of schizophrenia. Psychosom Med 1950; 12: 250-253.
49. Mackley CL. Body dysmorphic disorder. Dermatol Surg 2005; 31 (5): 553-558.
50. Phillips KA, Dufresne RG Jr. Body dysmorphic disorder: a guide for primary care physicians. Prim Care 2002; 29 (1) 99-111.
51. Bohne A, Wilhelm S, Keuthen NJ, Florin I, Baer L, Jenike MA. Prevalence of body dysmorphic disorder in a German college student sample. Psychiatry Res 2002; 31;109 (1): 101-104.
52. Altamura C, Paluello MM, Mundo E, Medda S, Mannu P. Clinical and subclinical body dysmorphic disorder. Eur Arch Psychiatry Clin Neurosci 2001; 251 (3): 105-108.
53. Phillips KA, Dufresne RG Jr, Wilkel CS, Vittorio CC. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol 2000; 42 (3): 436-441.
54. Phillips KA, Diaz S. Gender differences in body dysmorphic disorder. J Nerv Ment Dis 1997; 185: 570-577.
55. Hull SM, Cunliffe WJ, Hughes BR. Treatment of the depressed and dysmorphophobic acne patient. Clin Exp Dermatol 1991; 16: 210-211.
56. Patterson WM, Bienvenu OJ, Chodynicki MP, Janniger CK, Schwartz RA. Body dysmorphic disorder. Int J Dermatol 2001; 40 (11): 688-690.
57. Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry 1997; 19 (1): 29-35.
58. Gieler U, Stangier U, Niemeier V. Somatoforme Syndrome in der Dermatologie. In: Kapfhammer HP, Gündel H (eds.): Psychotherapie der Somatisierungsstörungen. Stuttgart - New York: Thieme-Verlag, 2001: 104-116.
59. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997; 137 (2): 246-250.
60. Studt H, Riehl A, Gollnick H. Acne conglobata: Persönlichkeit und seelische Folgen einer 13-cis-Retinsäure-Therapie. Erste Ergebnisse. Z Hautkr 1986; 61: 743-754.
61. Crerand CE, Phillips KA, Menard W, Fay C. Nonpsychiatric medical treatment of body dysmorphic disorder. Psychosomatics. 2005; 46 (6): 549-555.
62. Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998; 17: 291-296.
63. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107 (5): 707-713.
64. Augustin M, Wenninger K, Amon U, Schroth MJ, Kuster W, Chren M, Kupfer J, Gieler U. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 2004; 209 (1): 14-20.
65. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998; 134 (4): 454-458.
66. Stangier U, Gieler U, Ehlers A. Entwicklung eines Fragebogens zur Krankheitsbewältigung bei Hauterkrankungen (Marburger Haut-Fragebogen, MHF). Diagnostica 1997; 44: 30-40.
67. Stangier U, Gieler U, Ehlers A. Fragebögen zur Bewältigung von Hautkrankheiten. Göttingen, Hogrefe, 1996.
68. Stangier U, Ehlers A, Gieler U. Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess 2003; 15: 532-549.
69. Scholz O. Zum Einfluß von Streß und Streßverarbeitung auf das Krankheitsbild der Acne vulgaris. Dtsch Dermatol 1988; 36: 154-161.
70. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AJ. The quality of life in acne: a comparison with general medical conditions using questionnaires. Br J Dermatol 1999; 140: 672-676.
71. Niemeier V, Gieler U. Psychosomatische Aspekte der Akne. Haut 2004; 5: 192-197.
72. Braun-Falco O, Plewig G, Wolf HH, Burgdorf WHC, Landthaler M. Dermatologie und Venerologie Springer, Heidelberg - New York - Tokyo 2005, 876-900.
73. Böttcher V. Psychosoziales Umfeld des Akne-Patienten. Ärztl Kosmetol 1984; 14: 398.
74. Draelos ZK. Patient compliance: Enhancing clinician abilities and strategies. J Am Acad Dermatol 1995; 32(5): S42-48.
75. Koo J. The psychosocial impact of acne: Patients' perceptions. J Am Acad Dermatol 1995; 32: S 26-30.
76. Maisonneuve H, Cambazard F, Levy E, Thivolet J. [Evaluation of numbers and cost of severe acne in France]. Ann Dermatol Venereol 1987; 114: 1203-1209.
77. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986; 115: 386 (letter).
78. Feingold A. Good-looking people are not what we think. Psychol Bull 1992; 111: 304-341.
79. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989; 14: 194-198.
80. Shuster S, Fisher GH, Harris E. The effect of skin disease on self-image. Br J Dermatol 1978; 99: 18-19.
81. Yazici K, Baz K, Yazici AE, Kokturk A, Tot S, Demirseren D, Buturak V. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol 2004; 18 (4): 435-439.
82. Lucas CJ, Ojha A. Personality and acne. J Psychosom Res 1963; 7: 41.
83. Kenyon F. Psychosomatic aspects of acne: A controlled study. Trans St Johns Hospital Dermatol Society 1966; 52: 71-78.
84. Koblenzer C. Acne vulgaris. In: Psychocutaneous Disease. Orlando - New York - San Diego - London - San Francisco - Tokyo - Sydney - Toronto: Grune & Stratton, Inc., 1987: 313-317.
85. Polenghi MM, Zizak S, Molinari E. Emotions and acne. Dermatol Psychosom 2002; 3: 20-25.
86. Rapp DA, Brenes GA, Feldman SR, Fleischer AB Jr, Graham GF, Dailey M, Rapp SR. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol 2004; 151 (1): 183-189.
87. Van der Meeren HLM, Van der Schaar WW, Van den Hurk CMAM. The psychological impact of severe acne. Cutis 1985; 7: 84-86.
88. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
89. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-850.
90. Motley RJ, Finlay AY. Practical use of disability index in the routine management of acne. Clin Exp Dermatol 1992; 17: 1.
91. Garrie S, Garrie E. Anxiety and skin diseases. Cutis 1979; 22: 205-208.
92. Medansky R. Self-evaluation of acne and emotion: a pilot study. Psychosomatics 1981; 22: 379-383.
93. Rubinow DR, Peck GL. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17: 25-32.
94. Sayar K, Ugurad I, Kural Y, Acar B. The psychometric assessment of acne vulgaris Patients. Dermatol Psychosom 2000; 1: 62-65.
95. Hull PR, D'Arcy C. Acne, depression, and suicide. Dermatol Clin 2005; 23: 665-674.
96. Hill-Beuf A, Porter JDR. Children coping with impaired appearance: social and psychological influences. Gen Hosp Psychiat 1984; 6: 294-301.
97. Koblenzer CS. The emotional impact of chronic and disabling skin disease: a psychoanalytic perspective. Dermatol Clin 2005; 23 (4): 619-627.
98. Molinski H, Rechenberger I. Psychosomatik der Akne. Fortschr Med 1978; 95: 2149-2153.
99. Richards HL, Fortune DG, Weidmann A, Sweeney SK, Griffiths CE. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol 2004; 151 (6): 1227-1233.
100. Welp K, Gieler U. Akne vulgaris: Morphologische, endokrinologische und psychosomatische Aspekte. Z Hautkr 1990; 65: 1139-1145.
101. Jowett S, Ryan T. Skin disease and handicap: An analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425.
102. Lim CC, Tan TC. Personality, disability and acne in college students. Clin Exp Dermatol 1991; 16: 371.
103. Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol 1988; 18: 325-332.
104. Bosse K, Hünecke P. Entstellung - Erleben und Verarbeitung der äußeren Erscheinung. Beiträge zur Dermatologie 1980; 8: 251-269.
105. Degitz K, Plewig G. Adjunctive acne therapies. JDDG 2005; 3: 92-96.
106. Bergler R. Akne und Psyche - Plädoyer für eine integrative Therapie. TW Dermatologie 1990; 20: 442-443.
107. Kramer T, Garralda ME. Psychiatric disorders in adolescents in primary care. Br J Psychiat 1998; 173: 508-513.
108. Rechenberger I. Tiefenpsychologisch ausgerichtete Diagnostik und Behandlung von Hautkrankheiten. Verlag für Medizinische Psychologie, Vandenhoeck & Ruprecht, Göttingen, 1979.
109. Rasmussen JE, Smith SB. Patient concepts and misconceptions about acne. Arch Dermatol 1983; 119: 570-572.
110. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychosocial morbidity in mid-adolescence: a community based study. Br J Dermatol 2001; 145: 274-279.
111. Stangier U. Einstellung zur Akne und psychische Krankheitsverarbeitung - Ansätze für eine verbesserte Aknetherapie. Ärztl Kosmetol 1987; 17: 407- 408.
112. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and effect of isotretinoin. Br J Dermatol 1999; 140: 273-282.
113. Alt C. Symptomwahrnehmung. Symptomerleben, Körpererleben und Kontaktverhalten bei Jugendlichen mit Akne. S. Roderer Verlag, Regensburg, 1988.
114. Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol 2005; 152 (5): 1015-1021.
115. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19(3): 210-216.
116. Vogel P. Zur Acne excoriée des jeunes filles - Eine Symptomanalyse. Hautarzt 1974; 25: 333-336.
117. Sneddon J, Sneddon I. Acne excoriée: a prospective device. Clin Exp Dermatol 1983: 8: 65-68.
118. Hughes H, Brown B, Lawlis G, Fulton J. Treatment of acne vulgaris by biofeedback relaxation and cognitive imagery. J Psychosom Res 1983; 27: 185-191.
119. Friedrichs B. Hypnotherapie bei psychosomatischen Hauterscheinungen: Eine Falldarstellung. Experimentelle und klinische Hypnose 1985; 1: 181-185.
120. Shenefelt PD. Hypnosis in dermatology. Arch Dermatol 2000; 136: 393-399.
121. Gupta MA, Gupta AK. Olanzapine may be an effective adjunctive therapy in the management of acne excoriée: A case report. J Cutan Med Surg 2001; 5: 25-27.
122. Panconesi E, Hautmann G. Psychotherapeutic approach in acne treatment. Dermatology. 1998; 196 (1): 116-118.
123. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol. 2006 Mar; 54 (3):420-426.
124. Gieler U. Akne und Psyche. In: Praxis der Akne-Therapie. Friederich HC (ed): Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 1992: 57-88.